ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,776Medicare Part D Prescriptions Filled, Including Refills

Rank: 100 out of 944

$755K Total Retail Price of All Prescriptions

Rank: 48 out of 944

552 Patients Receiving at Least One Drug in Part D
88%Patients 65 Years and Older
22% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Wisconsin
Lower avg

Schedule Two
Controlled Substances

11% of this provider’s 552 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

12% of this provider’s 552 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

1% of this provider’s 10,348 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$64 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Wisconsin
SIMVASTATIN 549 533 1 1
FUROSEMIDE 417 368 2 6
OMEPRAZOLE 415 370 3 4
LEVOTHYROXINE SODIUM 373 329 4 2
METOPROLOL TARTRATE 282 261 5 8
ATENOLOL 272 267 6 11
ENALAPRIL MALEATE 255 235 7 43
AMLODIPINE BESYLATE 242 229 8 5
WARFARIN SODIUM 223 203 9 7
POTASSIUM CHLORIDE 216 197 10 15
HYDROCODONE-ACETAMINOPHEN 204 174 S3 11 10
RANITIDINE HCL 194 177 12 42
TRAZODONE HCL 176 156 13 45
HYDROCHLOROTHIAZIDE 169 161 14 9
METFORMIN HCL 152 140 15 12
GABAPENTIN 152 122 15 18
ALLOPURINOL 146 134 17 22
LOVASTATIN 138 135 18 26
MIRTAZAPINE 138 115 18 35
DIGOXIN 136 126 20 39
LISINOPRIL 136 124 20 3
DONEPEZIL HCL 135 135 22 24
QUETIAPINE FUMARATE 119 119 23 69
POLYETHYLENE GLYCOL 3350 113 100 24 41
CITALOPRAM HBR 109 105 25 19
FLUTICASONE PROPIONATE 108 89 26 40
KLOR-CON 10 107 107 27 115
CRESTOR 105 96 28 28
PREDNISONE 101 95 29 32
ATORVASTATIN CALCIUM 100 98 30 13
MORPHINE SULFATE ER 100 30 S2 30 80
TAMSULOSIN HCL 99 94 32 27
ALENDRONATE SODIUM 98 88 33 20
NAMENDA 96 96 34 37
OXYCODONE HCL 94 39 S2 35 50
TRIAMTERENE-HCTZ 93 93 36 33
DIOVAN 84 84 37 38
GLIPIZIDE 79 78 38 51
DOXAZOSIN MESYLATE 78 78 39 60
SPIRONOLACTONE 75 63 40 44
PROPRANOLOL HCL 73 71 41 103
OXYCODONE-ACETAMINOPHEN 72 35 S2 42 62
CARBIDOPA-LEVODOPA 69 69 43 77
CLOPIDOGREL 67 67 44 36
FENTANYL 67 49 S2 44 57
FLUOXETINE HCL 67 60 44 48
METOPROLOL SUCCINATE 65 65 47 14
CLONIDINE HCL 63 62 48 67
ADVAIR DISKUS 63 60 48 31
BENAZEPRIL HCL 62 62 50 66
TRAMADOL HCL 58 58 51 21
NIASPAN 54 54 52 76
VESICARE 54 51 52 138
TRIAMTERENE-HYDROCHLOROTHIAZID 53 53 54 137
PLAVIX 53 52 54 55
DETROL LA 52 52 56 159
LOSARTAN POTASSIUM 51 50 57 16
KETOCONAZOLE 50 35 58 248
DILTIAZEM ER 50 50 58 88
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 13, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.